Elena N. Pugacheva
Affiliations: | School of Medicine | West Virginia University, Morgantown, WV, United States |
Area:
Oncology, Biochemistry, PharmacologyGoogle:
"Elena Pugacheva"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ye Q, Wang J, Ducatman B, et al. (2023) Expression-Based Diagnosis, Treatment Selection, and Drug Development for Breast Cancer. International Journal of Molecular Sciences. 24 |
| Purazo ML, Ice RJ, Shimpi R, et al. (2023) NEDD9 Overexpression Causes Hyperproliferation of Luminal Cells and Cooperates with HER2 Oncogene in Tumor Initiation: A Novel Prognostic Marker in Breast Cancer. Cancers. 15 |
| Whately KM, Voronkova MA, Maskey A, et al. (2021) Nuclear Aurora-A kinase-induced hypoxia signaling drives early dissemination and metastasis in breast cancer: implications for detection of metastatic tumors. Oncogene |
| Addison JB, Voronkova MA, Fugett JH, et al. (2021) Functional hierarchy and cooperation of EMT master transcription factors in breast cancer metastasis. Molecular Cancer Research : McR |
| Sizemore G, McLaughlin S, Newman M, et al. (2020) Opening large-conductance potassium channels selectively induced cell death of triple-negative breast cancer. Bmc Cancer. 20: 595 |
| Wilson HE, Rhodes KK, Rodriguez D, et al. (2018) Human breast cancer xenograft model implicates peroxisome proliferator-activated receptor signaling as driver of cancer-induced muscle fatigue. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Wright ZC, Loskutov Y, Murphy D, et al. (2018) ADP-Ribosylation Factor-Like 2 (ARL2) regulates cilia stability and development of outer segments in rod photoreceptor neurons. Scientific Reports. 8: 16967 |
| Loskutov YV, Griffin CL, Marinak KM, et al. (2018) LPA signaling is regulated through the primary cilium: a novel target in glioblastoma. Oncogene |
| Ma PC, Wu X, Komo S, et al. (2018) PRC-2 epigenetic chromatin reprogramming in ALK-positive (ALK+) lung cancer initial emergence of precision drug resistance. Journal of Clinical Oncology. 36: 12020-12020 |
| Wu X, Lim Z, Komo S, et al. (2018) Mass spectrometry biomolecular omics profiling and imaging to dissect the initial emergence of molecular drug resistance in ALK-positive (ALK+) lung cancer. Journal of Clinical Oncology. 36: 12018-12018 |